{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T10:55:56Z","timestamp":1761562556185,"version":"build-2065373602"},"reference-count":48,"publisher":"MDPI AG","issue":"10","license":[{"start":{"date-parts":[[2019,9,27]],"date-time":"2019-09-27T00:00:00Z","timestamp":1569542400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100003718","name":"Korea Institute of Oriental Medicine","doi-asserted-by":"publisher","award":["K15250 and K18241"],"award-info":[{"award-number":["K15250 and K18241"]}],"id":[{"id":"10.13039\/501100003718","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JCM"],"abstract":"<jats:p>Conventional and herbal drugs are frequently used together to treat many disorders. Samryungbaekchul-san (SRS, a herbal formula) and otilonium bromide (OB, an antispasmodic agent) are widely used to treat diarrhea-predominant irritable bowel syndrome (D-IBS) in Eastern Asian countries. However, there have been no studies on the co-administration of SRS and OB. Therefore, we aimed to preliminarily assess the feasibility of SRS combined with OB for D-IBS treatment in a pilot double-blind, four-arm, parallel-group, randomized controlled trial (RCT), including 80 patients diagnosed with D-IBS according to the Rome III criteria. The patients were randomly assigned to four treatment groups and were administered drugs for eight weeks after a two-week preparatory period. Follow-up was conducted four weeks after the administration period. The primary outcome was evaluated by using a global D-IBS symptom improvement score; no statistically significant difference was observed between the groups. However, multiple logistic regression analysis of primary outcome scores shows that SRS significantly improved D-IBS symptoms (p &lt; 0.05). For secondary outcomes, better results were observed in the SRS + OB group, in terms of symptoms, including abdominal pain, discomfort, frequency of abdominal pain, and stool form than in OB alone or placebo groups (p &lt; 0.05). In conclusion, the co-administration of SRS and OB might be an effective and safe strategy for the treatment of D-IBS. Large-scale RCTs are warranted to further confirm and clarify these findings.<\/jats:p>","DOI":"10.3390\/jcm8101558","type":"journal-article","created":{"date-parts":[[2019,9,30]],"date-time":"2019-09-30T05:58:33Z","timestamp":1569823113000},"page":"1558","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["Effect of Samryungbaekchul-san Combined with Otilonium Bromide on Diarrhea-Predominant Irritable Bowel Syndrome: A Pilot Randomized Controlled Trial"],"prefix":"10.3390","volume":"8","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8387-2485","authenticated-orcid":false,"given":"Jin-Hyun","family":"Lee","sequence":"first","affiliation":[{"name":"Institute for Integrative Medicine, Catholic Kwandong University International St. Mary\u2019s Hospital, Incheon 22711, Korea"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5538-6674","authenticated-orcid":false,"given":"Joong Il","family":"Kim","sequence":"additional","affiliation":[{"name":"Future Medicine Division, Korea Institute of Oriental Medicine, Daejeon 34054, Korea"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Myong Ki","family":"Baeg","sequence":"additional","affiliation":[{"name":"Institute for Integrative Medicine, Catholic Kwandong University International St. Mary\u2019s Hospital, Incheon 22711, Korea"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yun-Young","family":"Sunwoo","sequence":"additional","affiliation":[{"name":"Iksoodang Korean Medical Clinic, Incheon 21425, Korea"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kwangsun","family":"Do","sequence":"additional","affiliation":[{"name":"Institute for Integrative Medicine, Catholic Kwandong University International St. Mary\u2019s Hospital, Incheon 22711, Korea"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jung-Han","family":"Lee","sequence":"additional","affiliation":[{"name":"Department of Korean Rehabilitation Medicine, Wonkwang University College of Korean Medicine, Iksan 54383, Korea"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hye-Jung","family":"Kim","sequence":"additional","affiliation":[{"name":"Institute for Integrative Medicine, Catholic Kwandong University International St. Mary\u2019s Hospital, Incheon 22711, Korea"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ja Sung","family":"Choi","sequence":"additional","affiliation":[{"name":"Institute for Integrative Medicine, Catholic Kwandong University International St. Mary\u2019s Hospital, Incheon 22711, Korea"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2977-1813","authenticated-orcid":false,"given":"Jayoung","family":"Kim","sequence":"additional","affiliation":[{"name":"Institute for Integrative Medicine, Catholic Kwandong University International St. Mary\u2019s Hospital, Incheon 22711, Korea"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8156-446X","authenticated-orcid":false,"given":"Chang-Seob","family":"Seo","sequence":"additional","affiliation":[{"name":"Herbal Medicine Research Division, Korea Institute of Oriental Medicine, Daejeon 34054, Korea"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hyeun-Kyoo","family":"Shin","sequence":"additional","affiliation":[{"name":"Herbal Medicine Research Division, Korea Institute of Oriental Medicine, Daejeon 34054, Korea"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7326-6366","authenticated-orcid":false,"given":"Hyekyung","family":"Ha","sequence":"additional","affiliation":[{"name":"Herbal Medicine Research Division, Korea Institute of Oriental Medicine, Daejeon 34054, Korea"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tae-Yong","family":"Park","sequence":"additional","affiliation":[{"name":"Institute for Integrative Medicine, Catholic Kwandong University International St. Mary\u2019s Hospital, Incheon 22711, Korea"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1968","published-online":{"date-parts":[[2019,9,27]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1111\/j.1365-2982.2005.00627.x","article-title":"Irritable bowel syndrome in developing countries\u2014A disorder of civilization or colonization?","volume":"17","author":"Gwee","year":"2005","journal-title":"Neurogastroenterol. Motil."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"186","DOI":"10.5056\/jnm.2010.16.2.186","article-title":"The differences in prevalence and sociodemographic characteristics of irritable bowel syndrome according to Rome II and Rome III","volume":"16","author":"Park","year":"2010","journal-title":"J. Neurogastroenterol. Motil."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1097\/MCG.0000000000000653","article-title":"World Gastroenterology Organisation global guidelines irritable bowel syndrome: A global perspective update September 2015","volume":"50","author":"Quigley","year":"2016","journal-title":"J. Clin. Gastroenterol."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"1171","DOI":"10.1046\/j.1365-2036.2002.01290.x","article-title":"Health-related quality of life among persons with irritable bowel syndrome: A systematic review","volume":"16","author":"Olden","year":"2002","journal-title":"Aliment Pharmacol. Ther."},{"key":"ref_5","doi-asserted-by":"crossref","unstructured":"Poulsen, C.H., Eplov, L.F., Hjorth\u00f8j, C., Hastrup, L.H., Eliasen, M., Dantoft, T.M., Schr\u00f6der, A., and J\u00f8rgensen, T. (2018). Irritable bowel symptoms, use of healthcare, costs, sickness and disability pension benefits: A long-term population-based study. Scand. J. Public Health.","DOI":"10.1177\/1403494818776168"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"10450","DOI":"10.3748\/wjg.v22.i47.10450","article-title":"Economic burden of irritable bowel syndrome in China","volume":"22","author":"Zhang","year":"2016","journal-title":"World J. Gastroenterol."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1186\/s12955-017-0611-2","article-title":"Health-related quality of life, work productivity, and indirect costs among patients with irritable bowel syndrome with diarrhea","volume":"15","author":"Buono","year":"2017","journal-title":"Health Qual. Life Outcomes"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"1540","DOI":"10.1038\/s41395-018-0262-x","article-title":"Work productivity and activity impairment in irritable bowel syndrome (IBS): A Multifaceted Problem","volume":"113","author":"Jakobsson","year":"2018","journal-title":"Am. J. Gastroenterol."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1001\/jama.2015.0954","article-title":"Irritable bowel syndrome: A clinical review","volume":"313","author":"Chey","year":"2015","journal-title":"JAMA"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"151","DOI":"10.5056\/jnm16214","article-title":"What is new in Rome IV","volume":"23","author":"Schmulson","year":"2017","journal-title":"J. Neurogastroenterol. Motil."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1111\/j.1365-2982.2007.01001.x","article-title":"Introduction. The Rome Foundation and Rome III","volume":"19","author":"Drossman","year":"2007","journal-title":"Neurogastroenterol. Motil."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"136","DOI":"10.7326\/0003-4819-133-2-200007180-00013","article-title":"Pharmacologic treatment of the irritable bowel syndrome: A systematic review of randomized, controlled trials","volume":"133","author":"Jailwala","year":"2000","journal-title":"Ann. Intern. Med."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"e42747","DOI":"10.5812\/aapm.42747","article-title":"Pharmacological approach for managing pain in irritable bowel syndrome: A review article","volume":"7","author":"Chen","year":"2017","journal-title":"Anesthesiol. Pain Med."},{"key":"ref_14","doi-asserted-by":"crossref","unstructured":"Vannucchi, M.G., and Evangelista, S. (2018). Experimental models of irritable bowel syndrome and the role of the enteric neurotransmission. J. Clin. Med., 7.","DOI":"10.3390\/jcm7010004"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"366","DOI":"10.3904\/kjm.2017.92.4.366","article-title":"Understanding the Rome IV: Irritable bowel syndrome and functional diarrhea","volume":"92","author":"Kim","year":"2017","journal-title":"Korean J. Med."},{"key":"ref_16","unstructured":"Weibert, E., and Stengel, A. (2019). The role of psychotherapy in the treatment of irritable bowel syndrome. Psychother. Psychosom. Med. Psychol."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"454","DOI":"10.3748\/wjg.14.454","article-title":"Effectiveness and safety of herbal medicines in the treatment of irritable bowel syndrome: A systematic review","volume":"14","author":"Shi","year":"2008","journal-title":"World J. Gastroenterol."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"1756284818820438","DOI":"10.1177\/1756284818820438","article-title":"Acupuncture and related therapies for treating irritable bowel syndrome: Overview of systematic reviews and network meta-analysis","volume":"12","author":"Wu","year":"2019","journal-title":"Ther. Adv. Gastroenterol."},{"key":"ref_19","first-page":"179","article-title":"Experimental studies on the efficacy of Samryungbaekchulsan","volume":"14","author":"Song","year":"1993","journal-title":"J. Korean Med."},{"key":"ref_20","first-page":"2586","article-title":"Effect of Shenling Baizhu Powder on serum proteomic changes in mice with Reserpine-induced spleen deficiency","volume":"35","author":"Fan","year":"2013","journal-title":"Chin. Tradit. Patent Med."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"77","DOI":"10.14374\/HFS.2015.23.1.077","article-title":"Frequency analysis of clinical prescriptions in the Korean Medicine Hospital, Pusan National University based on herb weight ratio(2)\u2014Focusing on prescriptions of herbal formula study textbook [Korean]","volume":"23","author":"Shin","year":"2015","journal-title":"Herb. Formula Sci."},{"key":"ref_22","first-page":"318","article-title":"Clinical observation of irritable bowel syndrome treated by shenlingbaizhu-san granule and trimebutine [Chinese]","volume":"27","author":"Chen","year":"2011","journal-title":"J. Pract. Tradit. Chin. Med."},{"key":"ref_23","first-page":"320","article-title":"Observation of sixty-five cases on Irritable Bowel Syndrome treated by Trimebutine and Shenlingbaizhu-san granule [Chinese]","volume":"26","author":"Duan","year":"2010","journal-title":"J. Pr. Tradit. Chin. Med."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"85","DOI":"10.18325\/jkmr.2017.27.4.85","article-title":"Systematic review on traditional Chinese Herbal Medicine treatment for antibiotic associated diarrhea","volume":"27","author":"Chang","year":"2017","journal-title":"J. Korean Med. Rehab."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1586\/17474124.2014.869477","article-title":"Irritable bowel syndrome: Focus on otilonium bromide","volume":"8","author":"Boeckxstaens","year":"2014","journal-title":"Expert Rev. Gastroenterol. Hepatol."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1007\/s00384-012-1598-0","article-title":"IBS and the role of otilonium bromide","volume":"28","author":"Boeckxstaens","year":"2013","journal-title":"Int. J. Colorectal. Dis."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"e728","DOI":"10.1111\/nmo.12197","article-title":"Chronic treatment with otilonium bromide induces changes in L-type Ca(2)(+) channel, tachykinins, and nitric oxide synthase expression in rat colon muscle coat","volume":"25","author":"Traini","year":"2013","journal-title":"Neurogastroenterol. Motil."},{"key":"ref_28","first-page":"e803","article-title":"Mechanisms of action of otilonium bromide (OB) in human cultured smooth muscle cells and rat colonic strips","volume":"25","author":"Gil","year":"2013","journal-title":"Neurogastroenterol. Motil."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"e180","DOI":"10.1111\/j.1365-2982.2010.01495.x","article-title":"Effect of otilonium bromide on contractile patterns in the human sigmoid colon","volume":"22","author":"Gallego","year":"2010","journal-title":"Neurogastroenterol. Motil."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1111\/j.1365-2036.2011.04730.x","article-title":"Randomised clinical trial: Otilonium bromide improves frequency of abdominal pain, severity of distention and time to relapse in patients with irritable bowel syndrome","volume":"34","author":"Clave","year":"2011","journal-title":"Aliment Pharm."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"12283","DOI":"10.3748\/wjg.v20.i34.12283","article-title":"Otilonium bromide in irritable bowel syndrome: A dose-ranging randomized double-blind placebo-controlled trial","volume":"20","author":"Reggiardo","year":"2014","journal-title":"World J. Gastroenterol."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1177\/1756283X16681708","article-title":"Efficacy of otilonium bromide in irritable bowel syndrome: A pooled analysis","volume":"10","author":"Clave","year":"2017","journal-title":"Ther. Adv. Gastroenterol."},{"key":"ref_33","first-page":"79","article-title":"Clinical and experimental study on the treatment of children diarrhea by granule of children-diarrhea fast-stopping","volume":"11","author":"Li","year":"1991","journal-title":"Zhong Xi Yi Jie He Za Zhi\/Chin. J. Modern Dev. Tradit. Med."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"e018362","DOI":"10.1136\/bmjopen-2017-018362","article-title":"Effect of herbal extract granules combined with otilonium bromide on irritable bowel syndrome with diarrhoea: A study protocol for a randomised controlled trial","volume":"7","author":"Kim","year":"2017","journal-title":"BMJ Open"},{"key":"ref_35","first-page":"824605","article-title":"Effect of korean herbal medicine combined with a probiotic mixture on diarrhea-dominant irritable bowel syndrome: A double-blind, randomized, placebo-controlled trial","volume":"2013","author":"Ko","year":"2013","journal-title":"eCAM"},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1097\/MCG.0b013e31823712b1","article-title":"The effect of a multispecies probiotic mixture on the symptoms and fecal microbiota in diarrhea-dominant irritable bowel syndrome: A randomized, double-blind, placebo-controlled trial","volume":"46","author":"Song","year":"2012","journal-title":"J. Clin. Gastroenterol."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1111\/j.1365-2982.2005.00695.x","article-title":"A randomized controlled trial of a probiotic combination VSL# 3 and placebo in irritable bowel syndrome with bloating","volume":"17","author":"Kim","year":"2005","journal-title":"Neurogastroenterol. Motil."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1016\/S0895-4356(03)00027-1","article-title":"Subject\u2019s global assessment of relief: An appropriate method to assess the impact of treatment on irritable bowel syndrome-related symptoms in clinical trials","volume":"56","author":"Koch","year":"2003","journal-title":"J. Clin. Epidemiol."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"920","DOI":"10.3109\/00365529709011203","article-title":"Stool form scale as a useful guide to intestinal transit time","volume":"32","author":"Lewis","year":"1997","journal-title":"Scand. J. Gastroenterol."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/j.gtc.2005.02.004","article-title":"Psychiatric and psychological dysfunction in irritable bowel syndrome and the role of psychological treatments","volume":"34","author":"Palsson","year":"2005","journal-title":"Gastroenterol. Clin. N. Am."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1186\/s13030-015-0031-7","article-title":"Effect of prolonged stress on the adrenal hormones of individuals with irritable bowel syndrome","volume":"9","author":"Sugaya","year":"2015","journal-title":"Biopsychosoc. Med."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1186\/2049-9256-2-4","article-title":"The relationship between irritable bowel syndrome and psychiatric disorders: From molecular changes to clinical manifestations","volume":"2","author":"Buga","year":"2014","journal-title":"J. Mol. Psychiatry"},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1177\/009286158902300208","article-title":"World health organization adverse reaction terminology dictionary","volume":"23","author":"Sills","year":"1989","journal-title":"Drug. Inf. J."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1111\/j.1365-2036.2008.03815.x","article-title":"Low-dose lactose in drugs neither increases breath hydrogen excretion nor causes gastrointestinal symptoms","volume":"28","author":"Montalto","year":"2008","journal-title":"Aliment Pharm."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"e13527","DOI":"10.1111\/nmo.13527","article-title":"Lactose intolerance but not lactose maldigestion is more frequent in patients with irritable bowel syndrome than in healthy controls: A meta-analysis","volume":"21","author":"Varju","year":"2019","journal-title":"Neurogastroenterol. Motil."},{"key":"ref_46","first-page":"232147","article-title":"Syndrome differentiation in Chinese herbal medicine for irritable bowel syndrome: A literature review of randomized trials","volume":"2013","author":"Li","year":"2013","journal-title":"Evid. Based Complement. Altern. Med"},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"203","DOI":"10.17480\/psk.2017.61.4.203","article-title":"Clinical implication of the lactose contents contained in oral drug formulations for lactose intolerant patients in Korea","volume":"61","author":"Cheon","year":"2017","journal-title":"Yakhak Hoeji"},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"70","DOI":"10.5056\/jnm.2012.18.1.70","article-title":"Gender role in irritable bowel syndrome: A comparison of irritable bowel syndrome module (ROME III) between male and female patients","volume":"18","author":"Anbardan","year":"2012","journal-title":"J. Neurogastroenterol. Motil."}],"container-title":["Journal of Clinical Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2077-0383\/8\/10\/1558\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T13:25:23Z","timestamp":1760189123000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2077-0383\/8\/10\/1558"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,9,27]]},"references-count":48,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2019,10]]}},"alternative-id":["jcm8101558"],"URL":"https:\/\/doi.org\/10.3390\/jcm8101558","relation":{},"ISSN":["2077-0383"],"issn-type":[{"type":"electronic","value":"2077-0383"}],"subject":[],"published":{"date-parts":[[2019,9,27]]}}}